846 related articles for article (PubMed ID: 15163723)
1. A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs.
Fenaux M; Opriessnig T; Halbur PG; Elvinger F; Meng XJ
J Virol; 2004 Jun; 78(12):6297-303. PubMed ID: 15163723
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy of experimental inactivated and live-attenuated chimeric porcine circovirus (PCV) 1-2b vaccines derived from PCV1 and PCV2b isolates originated in China.
Li J; Yu T; Wang X; Zhou J; Gao R; Zhang F; Gao X; Gao S; Liu X
Virol J; 2015 Jul; 12():113. PubMed ID: 26220290
[TBL] [Abstract][Full Text] [Related]
3. A candidate inactivated chimeric vaccine PCV1-2 constructed based on PCV1 and PCV2 isolates originating in China and its evaluation in conventional pigs in regard to protective efficacy against PCV2 infection.
Xujie L; Xiaobo W; Yi S; Jing F; Song G; Xiufan L
Microbiol Immunol; 2011 Apr; 55(4):254-66. PubMed ID: 21244470
[TBL] [Abstract][Full Text] [Related]
4. An experimental live chimeric porcine circovirus 1-2a vaccine decreases porcine circovirus 2b viremia when administered intramuscularly or orally in a porcine circovirus 2b and porcine reproductive and respiratory syndrome virus dual-challenge model.
Opriessnig T; Gomes-Neto JC; Hemann M; Shen HG; Beach NM; Huang Y; Halbur PG; Meng XJ
Microbiol Immunol; 2011 Dec; 55(12):863-73. PubMed ID: 21951266
[TBL] [Abstract][Full Text] [Related]
5. Novel chimeric porcine circovirus (PCV) with the capsid gene of the emerging PCV2b subtype cloned in the genomic backbone of the non-pathogenic PCV1 is attenuated in vivo and induces protective and cross-protective immunity against PCV2b and PCV2a subtypes in pigs.
Beach NM; Ramamoorthy S; Opriessnig T; Wu SQ; Meng XJ
Vaccine; 2010 Dec; 29(2):221-32. PubMed ID: 21044670
[TBL] [Abstract][Full Text] [Related]
6. A PCV2 vaccine based on genotype 2b is more effective than a 2a-based vaccine to protect against PCV2b or combined PCV2a/2b viremia in pigs with concurrent PCV2, PRRSV and PPV infection.
Opriessnig T; O'Neill K; Gerber PF; de Castro AM; Gimenéz-Lirola LG; Beach NM; Zhou L; Meng XJ; Wang C; Halbur PG
Vaccine; 2013 Jan; 31(3):487-94. PubMed ID: 23174198
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and pathogenicity of chimeric infectious DNA clones of pathogenic porcine circovirus type 2 (PCV2) and nonpathogenic PCV1 in weanling pigs.
Fenaux M; Opriessnig T; Halbur PG; Meng XJ
J Virol; 2003 Oct; 77(20):11232-43. PubMed ID: 14512571
[TBL] [Abstract][Full Text] [Related]
8. A live-attenuated chimeric porcine circovirus type 2 (PCV2) vaccine is transmitted to contact pigs but is not upregulated by concurrent infection with porcine parvovirus (PPV) and porcine reproductive and respiratory syndrome virus (PRRSV) and is efficacious in a PCV2b-PRRSV-PPV challenge model.
Opriessnig T; Shen HG; Pal N; Ramamoorthy S; Huang YW; Lager KM; Beach NM; Halbur PG; Meng XJ
Clin Vaccine Immunol; 2011 Aug; 18(8):1261-8. PubMed ID: 21653745
[TBL] [Abstract][Full Text] [Related]
9. Effect of porcine parvovirus vaccination on the development of PMWS in segregated early weaned pigs coinfected with type 2 porcine circovirus and porcine parvovirus.
Opriessnig T; Fenaux M; Yu S; Evans RB; Cavanaugh D; Gallup JM; Pallares FJ; Thacker EL; Lager KM; Meng XJ; Halbur PG
Vet Microbiol; 2004 Mar; 98(3-4):209-20. PubMed ID: 15036529
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a reformulated inactivated chimeric PCV1-2 vaccine based on clinical, virological, pathological and immunological examination under field conditions.
Seo HW; Han K; Oh Y; Park C; Chae C
Vaccine; 2012 Oct; 30(47):6671-7. PubMed ID: 22963801
[TBL] [Abstract][Full Text] [Related]
11. Expression of antigenic epitopes of porcine reproductive and respiratory syndrome virus (PRRSV) in a modified live-attenuated porcine circovirus type 2 (PCV2) vaccine virus (PCV1-2a) as a potential bivalent vaccine against both PCV2 and PRRSV.
Piñeyro PE; Kenney SP; Giménez-Lirola LG; Heffron CL; Matzinger SR; Opriessnig T; Meng XJ
Virus Res; 2015 Dec; 210():154-64. PubMed ID: 26239318
[TBL] [Abstract][Full Text] [Related]
12. Two amino acid mutations in the capsid protein of type 2 porcine circovirus (PCV2) enhanced PCV2 replication in vitro and attenuated the virus in vivo.
Fenaux M; Opriessnig T; Halbur PG; Elvinger F; Meng XJ
J Virol; 2004 Dec; 78(24):13440-6. PubMed ID: 15564454
[TBL] [Abstract][Full Text] [Related]
13. [Construction of infectious DNA clone of chimeric porcine circovirus type 1-2 and its immunogenicity in mice].
Yi S; Lina Z; Song G; Xiufan L
Wei Sheng Wu Xue Bao; 2008 Sep; 48(9):1234-40. PubMed ID: 19062650
[TBL] [Abstract][Full Text] [Related]
14. Protection of pigs against post-weaning multisystemic wasting syndrome by a recombinant adenovirus expressing the capsid protein of porcine circovirus type 2.
Wang X; Jiang P; Li Y; Jiang W; Dong X
Vet Microbiol; 2007 Apr; 121(3-4):215-24. PubMed ID: 17215092
[TBL] [Abstract][Full Text] [Related]
15. A chimeric virus created by DNA shuffling of the capsid genes of different subtypes of porcine circovirus type 2 (PCV2) in the backbone of the non-pathogenic PCV1 induces protective immunity against the predominant PCV2b and the emerging PCV2d in pigs.
Matzinger SR; Opriessnig T; Xiao CT; Catanzaro N; Beach NM; Slade DE; Nitzel GP; Meng XJ
Virology; 2016 Nov; 498():82-93. PubMed ID: 27564544
[TBL] [Abstract][Full Text] [Related]
16. Effect of porcine circovirus type 2 (PCV2) vaccination on porcine reproductive and respiratory syndrome virus (PRRSV) and PCV2 coinfection.
Opriessnig T; Madson DM; Prickett JR; Kuhar D; Lunney JK; Elsener J; Halbur PG
Vet Microbiol; 2008 Sep; 131(1-2):103-14. PubMed ID: 18430525
[TBL] [Abstract][Full Text] [Related]
17. Porcine circovirus type 2 infection decreases the efficacy of a modified live porcine reproductive and respiratory syndrome virus vaccine.
Opriessnig T; McKeown NE; Harmon KL; Meng XJ; Halbur PG
Clin Vaccine Immunol; 2006 Aug; 13(8):923-9. PubMed ID: 16893993
[TBL] [Abstract][Full Text] [Related]
18. Vaccination with inactivated or live-attenuated chimeric PCV1-2 results in decreased viremia in challenge-exposed pigs and may reduce transmission of PCV2.
Hemann M; Beach NM; Meng XJ; Halbur PG; Opriessnig T
Vet Microbiol; 2012 Jul; 158(1-2):180-6. PubMed ID: 22341313
[TBL] [Abstract][Full Text] [Related]
19. Reduction of porcine circovirus type 2 (PCV2) viremia by a reformulated inactivated chimeric PCV1-2 vaccine-induced humoral and cellular immunity after experimental PCV2 challenge.
Seo HW; Oh Y; Han K; Park C; Chae C
BMC Vet Res; 2012 Oct; 8():194. PubMed ID: 23078878
[TBL] [Abstract][Full Text] [Related]
20. Clinical, virological, immunological and pathological evaluation of four porcine circovirus type 2 vaccines.
Seo HW; Han K; Park C; Chae C
Vet J; 2014 Apr; 200(1):65-70. PubMed ID: 24618398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]